Day: July 1, 2024

Voltalia and Taqa Arabia pursue the development of the cluster combining renewable energy generation with green hydrogen production in Egypt

Written by Customer Service on . Posted in Public Companies.

Voltalia (Euronext Paris, ISIN code: FR0011995588), an international player in renewable energies, and its partner TAQA Arabia, signed a framework agreement during the Egypt-EU Investment Conference 2024, which was held on June 29 and 30 in Cairo. The Egypt-EU Investment Conference was held under the auspices of Ursula von der Leyen, President of the European Commission, and Abdel Fattah El-Sisi, President of the Arab Republic of Egypt. With its partner TAQA Arabia, Voltalia is continuing to develop a cluster combining renewable energy and green hydrogen production. The framework agreement is a continuation of a Memorandum of Understanding (MoU) signed in December 2022 to develop a cluster combining green hydrogen production with renewable power generation. The project will be implemented in two identical phases, each comprising a 500-megawatt...

Continue reading

Composition of Kalmar Corporation’s Shareholders’ Nomination Board

Written by Customer Service on . Posted in Public Companies.

KALMAR CORPORATION, STOCK EXCHANGE RELEASE, 1 July 2024 AT 9:15 AM (EEST) Composition of Kalmar Corporation’s Shareholders’ Nomination Board Kalmar Corporation’s (“Kalmar” or the “Company”) Shareholders’ Nomination Board (“Nomination Board”) has been appointed in accordance with the Charter of the Nomination Board approved by Cargotec Corporation’s (“Cargotec”) Annual General Meeting held on 30 May 2024, which also resolved on the partial demerger of Cargotec and the incorporation of Kalmar. The Nomination Board consists of four (4) members. According to the Charter of the Nomination Board, the members of the Nomination Board are appointed as follows: the two largest shareholders of class A shares are entitled to appoint one (1) member each, and the two largest shareholders of class B shares who do not own any class A shares, are entitled...

Continue reading

Atlas Luxco S.à r.l., a subsidiary of Atlas Investissement S.A.S., announces public offers to purchase all of the outstanding common shares and SDRs of Millicom International Cellular S.A. for USD 24.00 in cash per Common Share and per SDR

Written by Customer Service on . Posted in Mergers And Acquisitions.

Luxembourg, July 01, 2024 (GLOBE NEWSWIRE) — Press Release This announcement is not an offer, whether directly or indirectly, in Australia, Belarus, Canada, Hong Kong, Japan, New Zealand, Singapore, South Africa or Russia or in any other jurisdiction where such offer would be prohibited by applicable law pursuant to legislation, restrictions and regulations in the relevant jurisdiction. Shareholders not resident in Sweden or the United States who wish to accept the Offers (as defined below) must make inquiries concerning applicable legislation and possible tax consequences. Shareholders should refer to the offer restrictions included in the section titled “Important notice” at the end of this announcement and in the Offer to Purchase (as defined below) that will be published shortly before the beginning of the acceptance period...

Continue reading

Wendel joins Providence to support Globeducate, a leading international K-12 education group, through its next phase of growth

Written by Customer Service on . Posted in Mergers And Acquisitions.

Wendel joins Providence to support Globeducate, a leading international K-12 education group, through its next phase of growth Wendel (Euronext: MF.FP) announced today it has entered into an agreement with Providence Equity Partners, (“Providence”), a premier private equity firm specializing in growth-oriented investments in media, communications, education and technology, to invest in Globeducate, one of the world’s leading international K-12 education groups. Following the transaction, Providence, which has been a Globeducate shareholder since 2017, and Wendel will each own approximately 50% of Globeducate. As part of this transaction, Wendel would invest approximately €625 million alongside Providence, to hold a c.50% stake in the company’s capital based on an enterprise value of c.€2 billion1. The transaction is expected to complete...

Continue reading

Sword Group: Acquisitions in the UK

Written by Customer Service on . Posted in Mergers And Acquisitions.

The Group is making strategic acquisitions of 2 companies in ScotlandIACS, a CyberSecurity specialist based in AberdeenAAA, an Aberdeen-based company specialising in Artificial Intelligence IACS, is a micro-company based in Aberdeen and specialising in the digital security of industrial process control networks. It has developed expertise applicable to all the sectors covered by Sword to date in terms of CyberSecurity. The company’s revenue trend is €2.9 M per year and its EBITDA margin is 20%. The organic growth rate for IACS, once integrated into Sword, is budgeted at 15% per year. This company will be consolidated in the Group’s accounts with effect from 1 July 2024. AAA, a recruitment and staffing company based in Aberdeen, Scotland, was partially sold on 1 June 2023. AAA has restructured its offering around Artificial Intelligence...

Continue reading

Valneva Receives Marketing Authorization in Europe for the World’s First Chikungunya Vaccine, IXCHIQ®

Written by Customer Service on . Posted in Public Companies.

Saint Herblain (France), July 1, 2024 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that the European Commission (EC) has granted marketing authorization in Europe for Valneva’s single-dose vaccine, IXCHIQ®, for the prevention of disease caused by the chikungunya virus in individuals 18 years of age and older. The approval was unanimously endorsed by Member States following a stringent assessment by the European Medicines Agency (EMA)1. The EC decision marks the third approval the Company has received for IXCHIQ® following approval from the U.S. Food and Drug Administration (FDA) in November 2023 and Health Canada last month2. The Company expects to deliver the first doses in Europe in the fourth quarter of 2024. IXCHIQ® is the world’s only licensed chikungunya vaccine available to address...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.